China Biotech Services Holdings Limited announced with effect from the conclusion of the AGM Mr. Wang Zheng, an executive Director, was re-designated as a non-executive Director and ceased to be the Compliance Officer, an Authorised Representative and a Process Agent; Mr. Liu Xiaolin, the chairman and an executive Director, was appointed as the Compliance Officer in place of Mr. Wang, and currently being the other Authorised Representative and the other Process Agent, will remain as an Authorised Representative and a Process Agent; and Ms. Wong Miu Shun, the company secretary of the Company, was appointed as an Authorised Representative in place of Mr. Wang.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.35 HKD | -5.41% | +18.64% | -54.55% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-54.55% | 45.62M | |
+17.18% | 83.07B | |
-28.48% | 70.89B | |
+3.59% | 28.32B | |
-7.44% | 17.73B | |
+2.10% | 17.43B | |
+2.10% | 15.64B | |
+7.02% | 13.46B | |
+8.01% | 12.82B | |
+64.96% | 12.69B |
- Stock Market
- Equities
- 8037 Stock
- News China Biotech Services Holdings Limited
- China Biotech Services Holdings Limited Announces Management Changes